샘플 요청 목록

 카트 문의
시장보고서
상품코드
1551563

세계의 특수 의약품 시장

Specialty Pharmaceuticals
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 291 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

특수 의약품 세계 시장 규모는 2030년까지 9,200억 달러에 달할 것으로 전망

2023년 4,407억 달러로 추정되는 특수 의약품 세계 시장은 2023-2030년의 분석 기간 동안 연평균 11.1% 성장하여 2030년에는 9,200억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 암 치료 분야는 CAGR 12.9%를 기록하여 분석 기간 종료 시점에 3,963억 달러에 도달할 것으로 예상됩니다. 다발성 경화증 치료 영역의 성장률은 분석 기간 동안 CAGR 10.7%로 추정됩니다.

미국 시장은 약 1,201억 달러, 중국은 CAGR 15.3%로 성장할 것으로 예상

미국의 특수 의약품 시장은 2023년 1,201억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 2,011억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 15.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 8.1%와 9.7%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 8.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 특수 의약품 시장 - 주요 동향 및 촉진요인 정리

특수 의약품은 의료와 치료에 어떤 혁명을 일으키고 있는가?

특수 의약품은 지금까지 관리하기 어려웠던 복잡하고 만성적인 증상에 대해 표적화되고 효과적인 의약품을 제공함으로써 헬스케어와 치료에 혁명을 일으키고 있습니다. 이러한 의약품은 일반적으로 암, 자가면역질환, 희귀유전질환, HIV 등의 치료에 사용됩니다. 기존 의약품과 달리 특수 의약품은 종종 복잡한 제조 공정을 수반하고 특별한 취급이 필요하며 일반적으로 주사나 정맥 주사로 투여되지만 경구용 의약품도 존재합니다. 특수 의약품의 개발과 사용은 생명공학 및 개인 맞춤형 의료의 발전으로 촉진되고 있습니다. 특수 의약품의 영향력은 매우 크며, 보다 효과적인 치료법을 제공함으로써 환자의 예후를 개선할 뿐만 아니라 이전에는 치료 옵션이 제한적이거나 전혀 없었던 질병에 희망을 주고 있습니다. 전문 치료로의 전환은 의료 서비스의 질을 향상시키고, 보다 개인화되고 효과적인 치료 요법을 가능하게 하고 있습니다.

특수 의약품의 기능성을 높이는 혁신이란?

특수 의약품의 혁신은 약물 전달 시스템의 발전, 개인 맞춤형 의료 및 바이오시밀러 개발을 통해 그 기능을 향상시키고 있습니다. 중요한 혁신 중 하나는 나노입자, 리포좀 및 기타 운반체 시스템의 사용과 같은 약물 전달 방법의 개선으로 생체 이용률을 높이고, 특정 세포와 조직에 약물을 표적화하여 부작용을 줄이고 치료 결과를 개선할 수 있게 되었습니다. 유전체학 및 바이오마커의 발전으로 인한 개인 맞춤형 의료는 환자의 유전적 체질에 따라 맞춤형 치료를 가능하게 하고, 환자 개개인에게 보다 효과적인 특수 의약품을 보장합니다. 또한, 바이오시밀러(생물학적으로 유사한 오리지널 의약품)의 개발은 유사한 효능과 안전성 프로파일을 유지하면서 보다 비용 효율적인 대안을 제공할 수 있습니다. 이는 생명을 구하는 치료에 대한 접근성을 향상시킬 뿐만 아니라 시장 경쟁을 촉진하고 전문의약품의 총비용을 절감할 수 있습니다. 이러한 기술 혁신은 특수 의약품을 더 쉽게 이용할 수 있고, 더 효과적이며, 환자 개개인의 필요에 맞게 조정할 수 있게 함으로써 현대의 의료 환경을 변화시키고 있습니다.

특수 의약품은 환자 결과와 의료비용에 어떤 영향을 미칠까?

특수 의약품은 복잡한 증상을 가진 개인의 특정 요구에 맞는 치료를 제공함으로써 환자 결과에 큰 영향을 미치는 경우가 많습니다. 이러한 약물은 삶의 질을 획기적으로 개선하고, 증상을 보다 효과적으로 관리하며, 경우에 따라서는 이전에는 치료할 수 없었던 질병을 치료할 수 있는 가능성을 제공합니다. 만성 질환 환자의 경우, 특수 의약품은 질병의 재발 빈도와 중증도를 줄이고 입원율을 낮추며 전반적인 질병 부담을 줄일 수 있습니다. 그러나 특수 의약품의 고가성은 양날의 검으로, 이러한 약품은 엄청나게 비싸기 때문에 환자와 의료 시스템에 큰 도전이 될 수 있습니다. 이러한 치료제의 장기적인 효과는 입원이나 수술과 같은 다른 의료 비용을 절감할 수 있지만, 치료를 위한 초기 지출은 상당할 수 있습니다. 이 때문에 가격 책정, 보험 적용, 그리고 이러한 첨단 치료법을 제공하는 의료 시스템의 지속가능성에 대한 논의가 계속되고 있습니다. 비용 부담에도 불구하고 환자 결과에 큰 영향을 미치는 특수 의약품은 현대 의료에 있어 매우 중요한 요소이며, 접근성과 경제성의 균형을 맞추기 위한 노력은 계속되고 있습니다.

특수 의약품 시장의 성장을 가속하는 트렌드는 무엇인가?

만성질환 및 희귀질환 증가, 생명공학의 발전, 개인맞춤형 의료의 부상 등 여러 가지 트렌드가 특수 의약품 시장의 성장을 주도하고 있습니다. 전 세계 인구의 고령화와 암, 당뇨병, 자가면역질환과 같은 만성질환의 유병률이 증가함에 따라, 표적화되고 효과적인 치료법에 대한 수요가 증가하고 있습니다. 생명공학의 발전은 이러한 질병을 더 정확하게, 더 적은 부작용으로 치료할 수 있는 새로운 전문 의약품 개발에도 박차를 가하고 있습니다. 개인 맞춤형 의료로의 전환도 중요한 원동력입니다. 개인맞춤의료는 환자 개개인에 맞는 치료법 개발에 중점을 두기 때문에 치료 성과 향상과 자원의 효율적 활용으로 이어지는 경우가 많습니다. 또한 희귀질환 치료제로 개발된 희귀의약품(희귀질환 치료제)의 등장으로 신흥국 시장이 개척되고 연구개발에 많은 투자가 이루어지고 있습니다. 규제 혜택과 높은 투자 수익을 기대할 수 있어 제약사들은 이 분야를 계속 개척하고 있습니다. 이러한 추세는 미충족 의료 수요를 충족시키고, 복잡하고 희귀한 질환을 앓고 있는 환자들에게 희망을 주며, 헬스케어 혁신의 미래를 주도하는 특수 의약품의 역할이 확대되고 있음을 보여줍니다.

조사 대상 기업 예시(총 51건)

  • Cigna Healthcare
  • CVS Health Corporation
  • Datex Corporation
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • Humana Inc.
  • Hyphens Pharma International Limited
  • Hyphens Pharma Pte Ltd.
  • Kroger Specialty Pharmacy
  • McKesson Corporation
  • Merck Animal Health
  • SERB S.a.r.l.
  • STADA Arzneimittel AG
  • Terso Solutions, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.09.19

Global Specialty Pharmaceuticals Market to Reach US$920.0 Billion by 2030

The global market for Specialty Pharmaceuticals estimated at US$440.7 Billion in the year 2023, is expected to reach US$920.0 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$396.3 Billion by the end of the analysis period. Growth in the Multiple Sclerosis Therapeutic Area segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$120.1 Billion While China is Forecast to Grow at 15.3% CAGR

The Specialty Pharmaceuticals market in the U.S. is estimated at US$120.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$201.1 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 9.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Global Specialty Pharmaceuticals Market - Key Trends and Drivers Summarized

How Are Specialty Pharmaceuticals Revolutionizing Healthcare and Treatment?

Specialty pharmaceuticals are revolutionizing healthcare and treatment by offering targeted, high-efficacy medications for complex and chronic conditions that were previously difficult to manage. These drugs are typically used to treat conditions such as cancer, autoimmune disorders, rare genetic diseases, and HIV, among others. Unlike traditional pharmaceuticals, specialty drugs often involve complex manufacturing processes, require special handling, and are usually administered through injection or infusion, though oral forms also exist. Their development and use are driven by advancements in biotechnology and personalized medicine, which allow for more precise targeting of diseases at the molecular level. The impact of specialty pharmaceuticals is profound, as they not only improve patient outcomes by providing more effective treatments but also offer hope for conditions that had limited or no treatment options in the past. This shift towards specialized care is enhancing the overall quality of healthcare, enabling more personalized and effective treatment regimens.

What Innovations Are Enhancing the Functionality of Specialty Pharmaceuticals?

Innovations in specialty pharmaceuticals are enhancing their functionality through advancements in drug delivery systems, personalized medicine, and the development of biosimilars. One of the key innovations is the improvement in drug delivery methods, such as the use of nanoparticles, liposomes, and other carrier systems that enhance the bioavailability and targeting of drugs to specific cells or tissues, reducing side effects and improving therapeutic outcomes. Personalized medicine, driven by advances in genomics and biomarkers, is allowing for the customization of treatments based on a patient’s genetic makeup, ensuring that specialty pharmaceuticals are more effective for individual patients. Additionally, the development of biosimilars—biologically similar versions of original specialty drugs—offers a more cost-effective alternative while maintaining similar efficacy and safety profiles. This not only increases access to life-saving treatments but also drives competition in the market, potentially reducing the overall cost of specialty medications. These innovations are making specialty pharmaceuticals more accessible, effective, and tailored to the needs of individual patients, thereby transforming the landscape of modern healthcare.

How Do Specialty Pharmaceuticals Impact Patient Outcomes and Healthcare Costs?

Specialty pharmaceuticals have a significant impact on patient outcomes by providing treatments that are often more effective and tailored to the specific needs of individuals with complex conditions. These drugs can dramatically improve quality of life, manage symptoms more effectively, and, in some cases, offer a potential cure for previously untreatable diseases. For patients with chronic conditions, specialty pharmaceuticals can reduce the frequency and severity of disease flare-ups, lower hospitalization rates, and decrease the overall burden of illness. However, the high cost of specialty pharmaceuticals is a double-edged sword, as these medications can be prohibitively expensive, leading to significant challenges for patients and healthcare systems. While the long-term benefits of these drugs can reduce other healthcare costs, such as hospitalizations and surgeries, the initial outlay for treatment can be substantial. This has led to ongoing debates about pricing, insurance coverage, and the sustainability of healthcare systems in providing these advanced treatments. Despite the costs, the profound impact on patient outcomes makes specialty pharmaceuticals a crucial component of modern healthcare, driving ongoing efforts to balance access with affordability.

What Trends Are Driving Growth in the Specialty Pharmaceuticals Market?

Several trends are driving growth in the specialty pharmaceuticals market, including the increasing prevalence of chronic and rare diseases, advancements in biotechnology, and the rise of personalized medicine. As the global population ages and the incidence of chronic conditions like cancer, diabetes, and autoimmune diseases rises, the demand for targeted, effective treatments is growing. Advancements in biotechnology are also fueling the development of new specialty drugs that can address these conditions more precisely and with fewer side effects. The shift towards personalized medicine is another significant driver, as it emphasizes the development of therapies tailored to the individual patient, often leading to better outcomes and more efficient use of resources. Additionally, the emergence of orphan drugs—specialty pharmaceuticals designed to treat rare diseases—has opened new markets and driven significant investment in research and development. Regulatory incentives and the potential for high returns on investment are encouraging pharmaceutical companies to continue exploring this field. These trends underscore the expanding role of specialty pharmaceuticals in addressing unmet medical needs, offering hope for patients with complex and rare conditions, and driving the future of healthcare innovation.

Select Competitors (Total 51 Featured) -

  • Cigna Healthcare
  • CVS Health Corporation
  • Datex Corporation
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • Humana Inc.
  • Hyphens Pharma International Limited
  • Hyphens Pharma Pte Ltd.
  • Kroger Specialty Pharmacy
  • McKesson Corporation
  • Merck Animal Health
  • SERB S.a.r.l.
  • STADA Arzneimittel AG
  • Terso Solutions, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Specialty Pharmaceuticals - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Growth in Biologics Driving the Expansion of the Specialty Pharmaceuticals Market
    • Advancements in Targeted Therapies Offering New Treatment Avenues
    • Increased Prevalence of Chronic Diseases Fueling Demand for Specialty Medications
    • Regulatory Incentives Promoting Orphan Drug Development and Approvals
    • Expansion of Personalized Medicine and Its Influence on Specialty Pharma
    • Market Dynamics Shaped by Patent Expiries and the Emergence of Biosimilars
    • Insurance Coverage and Reimbursement Challenges Affecting Patient Access
    • Future Trends in Genomics and Gene Therapy Impacting Specialty Pharmaceuticals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Specialty Pharmaceuticals Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Inflammatory Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Offline Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Offline Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Offline Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • JAPAN
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • CHINA
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • EUROPE
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Specialty Pharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • FRANCE
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • GERMANY
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • INDIA
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Specialty Pharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Specialty Pharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
  • AFRICA
    • Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제